[1] Pötter R,Haiemeder C,Van LE,et al. Recommendations from gynaecological (GYN) GEC ESTRO working group (Ⅱ):concepts and terms in 3D image-based treatment planning in cervix cancer brachytherapy-3D dose volume parameters and aspects of 3D image-based anatomy,radiation physics,radiobiology[J].Radiother Oncol,2006,78(1):67-77.DOI:10.1016/j.radonc.2005.11.014.
[2] Epstein E,Testa A,Gaurilcikas A,et al. Early-stage cervical cancer:Tumor delineation by magnetic resonance imaging and ultrasound — A European multicenter trial ☆☆☆[J].Gynecol Oncol,2013,128(3):449-53.DOI:10.1016/j.ygyno.2012.09.025.
[3] Schmid MP,Pötter R,Brader P,et al. Feasibility of transrectal ultrasonography for assessment of cervical cancer[J].Strahlenther Onkol,2013,189(2):123-8.DOI:10.1007/s00066-012-0258-1.
[4] Grover S,Harkenrider MM,Cho LP,et al. Image Guided Cervical Brachytherapy:2014 Survey of the American Brachytherapy Society[J].Int J Radiat Oncol Biol Phys,2016,94(3):598-604.DOI:10.1016/j.ijrobp.2015.11.024.
[5] Viswanathan AN,Erickson BA.Three-Dimensional Imaging in Gynecologic Brachytherapy:A Survey of the American Brachytherapy Society[J].Int J Radiat Oncol Biol Phys,2010,76(1):104.DOI:10.1016/j.ijrobp.2009.01.043.
[6] Wang F,Tang Q,Lv G,et al. Comparison of computed tomography and magnetic resonance imaging in cervical cancer brachytherapy:A systematic review[J].Brachytherapy,2016,16(2):353.DOI:10.1016/j.brachy.2016.11.001.
[7] Eskander RN,Scanderbeg D,Saenz CC,et al. Comparison of computed tomography and magnetic resonance imaging in cervical cancer brachytherapy target and normal tissue contouring[J].Int J Gynecol Cancer,2010,20(1):47.DOI:10.1111/IGC.0b013e3181c4a627.
[8] Bhavana R,Patel FD,Parsee T,et al. A study to assess the feasibility of using CT (±diagnostic MRI) instead of MRI at brachytherapy in image guided brachytherapy in cervical cancer[J].J Radiother Pract,2014,13(4):438-446.DOI:10.1017/S1460396914000053.
[9] PetricP,Hudej R,Rogelj P,et al. Uncertainties of target volume delineation in MRI guided adaptive brachytherapy of cervix cancer:A multi-institutional study[J]. Radiother Oncol,2013,107(1):6.DOI:10.1016/j.radonc.2013.01.014.
[10] Dimopoulos JC,Schard G,Berger D,et al. Systematic evaluation of MRI findings in different stages of treatment of cervical cancer:Potential of MRI on delineation of target,pathoanatomic structures,and organs at risk[J].Int J Radiat Oncol Biol Phys,2006,64(5):1380-1388.DOI:10.1016/j.ijrobp.2005.10.017.
[11] Pötter R,Dimopoulos J,Georg P,et al. Clinical impact of MRI assisted dose volume adaptation and dose escalation in brachytherapy of locally advanced cervix cancer[J].Radiother Oncol,2007,83(2):148-155.DOI:10.1016/j.radonc.2007.04.012.
[12] Fischerova D,Cibula D,Stenhova H,et al. Transrectal ultrasound and magnetic resonance imaging in staging of early cervical cancer[J].Int J Gynecol Cancer,2008,18(4):766.DOI:10.1111/j.1525-1438.2007.01072.x.
[13] Chiappa V,Legge AD,Valentini AL,et al. Agreement of two-dimensional and three-dimensional transvaginal ultrasound with magnetic resonance imaging in assessment of parametrial infiltration in cervical cancer[J].Ultrasound Obstet Gynecol,2015,45(4):459-69.DOI:10.1002/uog.14637.
[14] St-Amant P,Foster W,Froment MA,et al. Use of 3D transabdominal ultrasound imaging for treatment planning in cervical cancer brachytherapy:Comparison to magnetic resonance and computed tomography[J].Brachytherapy,2017.DOI:10.1016/j.brachy.2017.03.006.
[15] Nesvacil N,Schmid MP,Pötter R,et al. Combining transrectal ultrasound and CT for image-guided adaptive brachytherapy of cervical cancer:Proof of concept[J].Brachytherapy,2016,15(6):839.DOI:10.1016/j.brachy.2016.08.009.
[16] 汪侠,李振华,解宝江.彩色多普勒超声对宫颈癌盆腔淋巴结转移的诊断价值[J].实用癌症杂志,2016,31(6):1009-1011.DOI:10.3969/j.issn.1001-5930.2016.06.043.
Wang X,Li ZH,Xie BJ.Value of color doppler ultrasound in the diagnosis of pelvic lymph nodes metastases in patients with carcinoma of cervix[J].Prac J Cancer,2016,31(6):1009-1011.DOI:10.3969/j.issn.1001-5930.2016.06.043.
[17] Testa AC,Ludovisi M,Manfredi R,et al. Transvaginal ultrasonography and magnetic resonance imaging for assessment of presence,size and extent of invasive cervical cancer[J].Ultrasound Obstet Gynecol,2009,34(3):335-44.DOI:10.1002/uog.7325.
[18] Pinkavova I,Fischerova D,Zikan M,et al. Transrectal ultrasound and magnetic resonance imaging in the evaluation of tumor size following neoadjuvant chemotherapy for locally advanced cervical cancer[J].Ultrasound Obstet Gynecol,2013,42(6):705-12.DOI:10.1002/uog.12455.
[19] Hegazy N,Pötter R,Kirisits C,et al. High-risk clinical target volume delineation in CT-guided cervical cancer brachytherapy:Impact of information from FIGO stage with or without systematic inclusion of 3D documentation of clinical gynecological examination[J].Acta Oncol,2013,52(7):1345-52.DOI:10.1093/jjco/hys010.
[20] Tamaki T,Miyaura K,Murakami T,et al. The use of trans-applicator intracavitary ultrasonography in brachytherapy for cervical cancer:phantom study of a novel approach to 3D image-guided brachytherapy[J].J Contemp Brachytherapy,2017,9(2):151-157.DOI:10.5114/jcb.2017.66588.
[21] Taggar A,Phan T,Traptow L,et al. Cervical Cancer Brachytherapy in Canada:A Focus on Interstitial Brachytherapy Utilization[J].Int J Radiat Oncol Biol Phys,2016,96(2S):E309.DOI:10.1016/j.brachy.2016.10.009.
[22] Van DS,Bernshaw D.Ultrasound-based conformal planning for gynaecological brachytherapy[J].J Med Imaging Radiat Oncol,2008,52(1):77-84.DOI:10.1111/j.1440-1673.2007.01917.x.
[23] Mahantshetty U,Khanna N,Swamidas J,et al. Trans-abdominal ultrasound (US) and magnetic resonance imaging (MRI) correlation for conformal intracavitary brachytherapy in carcinoma of the uterine cervix[J].Radiother Oncol,2012,102(1):130-4.DOI:10.1016/j.radonc.2011.08.001.
[24] Van DS,Kondalsamy-Chennakesavan S,Schneider M,et al. Comparison of measurements of the uterus and cervix obtained by magnetic resonance and transabdominal ultrasound imaging to identify the brachytherapy target in patients with cervix cancer[J].Int J Radiat Oncol Biol Phys,2014,88(4):860.DOI:10.1016/j.ijrobp.2014.06.047.
[25] Schmid MP,Nesvacil N,Pötter R,et al. Transrectal ultrasound for image-guided adaptive brachytherapy in cervix cancer-An alternative to MRI for target definition?[J].Radiother Oncol,2016,120(3):467-472.DOI:10.1016/j.radonc.2016.01.021.
[26] Narayan K,Van DS,Bernshaw D,et al. Ultrasound guided conformal brachytherapy of cervix cancer:survival,patterns of failure,and late complications[J].J Gynecol Oncol,2014,25(3):206.DOI:10.3802/jgo.2014.25.3.206.
[27] Van DS,Narayan K,Fisher R,et al. Conformal brachytherapy planning for cervical cancer using transabdominal ultrasound[J].Int J Radiat Oncol Biol Phys,2009,75(1):64-70.DOI:10.1016/j.ijrobp.2008.10.057.
[28] Pötter R,Georg P,Dimopoulos JC,et al. Clinical outcome of protocol based image (MRI) guided adaptive brachytherapy combined with 3D conformal radiotherapy with or without chemotherapy in patients with locally advanced cervical cancer[J].Radiother Oncol,2011,100(1):116.DOI:10.1016/j.radonc.2011.07.012. |